Autologous hematopoietic stem cell transplant is linked to less disability and lower relapse rates than other disease-modifying therapies for patients with secondary progressive multiple sclerosis.
WEDNESDAY, Dec. 28, 2022 (HealthDay News) A new study is adding to evidence that people with multiple sclerosis can benefit from a type of stem cell transplant including
A new study is adding to evidence that people with multiple sclerosis can benefit from a type of stem cell transplant including some patients who are in a more advanced phase of the disease.